Nutrition and the surgical patient: Triumphs and challenges

Surgeon

Volumn 3, Issue 3, 2005, Pages 139-144

  Heys, S D ^a   Schofield, A C ^a   Wahle, K W J ^b   Garcia Caballero, M ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Nutrition; Surgical patients

Indexed keywords

ANTINEOPLASTIC AGENT; ARGININE; DOCETAXEL; ESSENTIAL FATTY ACID; GLUTAMINE; IMMUNAID; PACLITAXEL; RNA; UNCLASSIFIED DRUG;

ARTICLE; BODY MASS; BREAST CANCER; CLINICAL PRACTICE; DIET SUPPLEMENTATION; HUMAN; IMMUNE SYSTEM; IMPACT; LENGTH OF STAY; MALNUTRITION; MORBIDITY; NUTRITIONAL HEALTH; NUTRITIONAL SUPPORT; OBESITY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL PATIENT; TOTAL PARENTERAL NUTRITION; WEIGHT REDUCTION;

EID: 21644451979     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(05)80033-2     Document Type: Article

References (46)

1. World Health Organisation. Obesity: preventing and managing the Global Epidemic. World health organisation, Geneva, 2000. [Technical Support series No. 894].
2. Studley HO. Percentage of weight loss. A basic indicator of surgical risk in patients with chronic peptic ulcer. JAMA 1936; 106: 458-60.
3. Detsky AS, Baker JP, O'Rourke K, Johnston N, Whitwell J, Mendelson RA et al. Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery. J Parenter Enteral Nutr 1987; 11: 440-46.
4. Heyland DK, Montalvo M, MacDonald S, Keefe L, Su XY, Drover JW. Total parenteral nutrition in the surgical patient: a meta-analysis. Can J Surg 2001;44: 102-11.
5. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical practice. N Engl J Med 1991; 325: 525-32
6. Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient. JAMA 1998; 280: 2013-19.
7. Levine GM, Deren JJ, Steiger E, Zinno R. Role of oral intake in the maintenance of gut mass and disaccharide activity. Gastroenterology 1974; 67: 975-82.
8. Wilmore D, Smith R, O'Dwyer S, Jacobs DO, Ziegler TR, Wang XD. The gut: a central organ after surgical stress. Surgery 1988; 104: 917-23.
9. Fong Y, Marano MA, Barber A, He W, Moldawer LL, Bushman ED et al. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 1999; 210: 449-56.
10. Heys SD, Eremin O, Broom J. Surgical Nutrition. In: Paterson-Brown, editor. Core topics in general and Emergency Surgery. WB Saunders 2001. p. 419-46.
11. Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, Heyland DK. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients: A systematic review of the literature. Nutrition 2004; 20: 843-48.
12. Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ 2004; 328: 1407.
13. Heys SD, Gough DB, Khan L, Eremin O. Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg 1996; 83: 608-19.
14. Kirk H, Heys SD. Immunonutrition. Br J Surg 2003; 90: 1459-60.
15. Brittenden J, Heys SD, Eremin O. Immunological properties of L-arginine. In: Eremin O, editor. L-arginine: biological aspects and clinical characteristics. Austin: RG Landes Co; 1997. p. 27-77.
16. Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 1990; 108: 331-337.
17. Brittenden J, Park KG, Heys SD, Ross C, Abby J, Ah-See A et al. L-arginine stimulates host defences in patients with breast cancer. Surgery 1994;115: 205-12.
18. Purasiri P, Ashby J, Heys SD, Eremin O. Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer. Cancer Immunol Immunother 1994; 39: 217-22.
19. Purasiri P, McKechnie A, Heys SD, Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 1997; 92: 166-72.
20. Khan AL, Heys SD, Eremin O. Synthetic polyribonucleotides: current role and potential use in oncological practice. Eur J Surg Oncol 1995; 21: 224-27.
21. Heys SD, Schofield A, Wahle KW. Immunonutrition in clinical practice: what is the current evidence? Nutr Hosp 2004; 19: 325-32.
22. Heys SD and Ashkanani F. Glutamine. Br J Surg 1999; 86: 289-90.
23. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30: 2022-29.
24. Cerra FB, Lehman S, Konstantinides N, Konstantinides F, Shronts EP, Holman R. Effect of enteral nutrition on in vitro tests of immune function in ICU patients. A preliminary report. Nutrition 1990; 6: 84-87.
25. Cerra FB, Lehmann S, Konstantinides N, Dzik J, Fish J, Konstantinides F et al. Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition 1991; 7: 193-99.
26. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229: 467-77.
27. Beale RJ, Bryg D, Bihari DJ. Immunonutrition in the critically ill: A systematic review of clinical outcome. Crit Care Med 1999; 27: 2799-805.
28. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944-53.
29. Braga M, Gianotti L, Vignali A, Di Carlo V. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132: 805-14.
30. Heys SD. Targeted nutrition in the critically ill: a therapeutic modality for the new millenium. Nutrition 2001; 17: 57-58.
31. Heyland DK, Samis A. Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med 2003; 29: 669-71.
32. Lorente JA, Landin L, dePablo R, Renes E, Liste D. L-arginine pathway in sepsis syndrome. Crit Care Med 1993; 21: 1287-95.
33. Gellerich FN, Trumbeckaite S, Hertel K, Zierz S, Muller-Werdan U, Werdan K et al. Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock 1999; 11: 336-41.
34. Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993; 264: G143-G149.
35. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002;122: 1763-70.
36. Cottam DR, Schaefer PA, Shaftan GW, Velcu L, Angus LD. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 2002; 12: 335-42.
37. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
38. Heys SD, Park KG, McNurlan MA, Milne E, Eremin O, Wernerman J et al. Stimulation of protein synthesis in human tumour by parenteral nutrition: evidence for modulation of tumour growth. Br J Surg 1991; 78: 483-87.
39. McNurlan MA, Essen P, Heys SD, Buchan V, Garlick PJ and Wernerman J. Measurement of protein synthesis in human skeletal muscle: further validation of the "flooding" technique Clin Sci (London) 1991; 81: 557-64.
40. Park KG, Heys SD, Blessing K, Kelly P, McNurlan MA, Eremin O, Garlick PJ. Stimulation of human breast cancers, by dietary L-arginine. Clin Sci (London) 1992; 82: 413-17.
41. Heys SD, Ogston K, Miller I, Hutcheon AW, Walker LG, Sarkar TK et al. Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. Int J Oncol 1998; 12: 221-25.
42. Majumder B, Wahle KWJ, Moir S, Schofield A, Choe SN, Farquharson A et al. Conjugated linolcic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J 2002; 16: 1447-49.
43. Schofield AC, Fite A, Wahle KWJ, Heys SD. Dietary fatty acids modulate the anti-tumour effect of docetaxel chemotherapy in breast cancer cells. Proc Am Assoc Cancer Res 2002; A4557.
44. Wu H-C, Arthur JR, Wahle KWJ. Regulation of phospholipid glutathione peroxidase (PHGPx) gene expression in human endothelial cells. Chem Phys Lipids 1998; 94: 174.
45. Ochoa JJ, Farquharson AJ, Grant I, Moffat LE, Heys SD, Wahle KW. Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 2004; 25: 1185-91.
46. Wahle KWJ, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr Soc 2003; 62: 349-60.